Literature DB >> 7027594

Diagnosis of respiratory syncytial virus infection in the bovine respiratory tract by immunofluorescence.

L H Thomas, E J Stott.   

Abstract

Direct staining of nasopharyngeal smears with hyperimmune bovine serum raised against respiratory syncytial virus (RSV) and conjugated with fluorescein isothyocyanate was compared with virus isolation from 14 experimentally infected animals. Twenty-four out of 107 specimens examined were positive by the fluorescent antibody (FA) method and 21 out of 107 by virus isolation. Most of the FA positives (81 per cent) were detected after the ninth day of infection whereas 80 per cent of virus isolations were made before this time. Only one false positive (one out of 57 specimens) was detected by the FA method in nine uninfected control animals. Non-specific fluorescence presented some problems when examining nasopharyngeal material. The same conjugate was found to be more useful in detecting RSV antigen in lung tissue of eight experimentally infected animals and 11 out of 22 naturally occurring cases of calf pneumonia from five outbreaks of disease. In three of the outbreaks the diagnosis was confirmed by virus isolation and serology. The dominating histopathological response in both the experimental and the natural disease was an acute bronchiolitis and alveolitis. The finding of RSV antigen in association with these lesions provides further evidence for the role of RSV as a respiratory pathogen of cattle.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7027594     DOI: 10.1136/vr.108.20.432

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  10 in total

Review 1.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 2.  Bovine respiratory syncytial virus (BRSV): a review.

Authors:  L E Larsen
Journal:  Acta Vet Scand       Date:  2000       Impact factor: 1.695

3.  Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves.

Authors:  G Taylor; L H Thomas; S G Wyld; J Furze; P Sopp; C J Howard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  Application of a modified indirect fluorescent antibody test to the detection of antibodies to bovine respiratory syncytial virus in Ontario cattle.

Authors:  J A Lynch; J B Derbyshire
Journal:  Can J Vet Res       Date:  1986-07       Impact factor: 1.310

5.  Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins.

Authors:  Jean-Francois Valarcher; Julie Furze; Sara Wyld; Roy Cook; Karl-Klaus Conzelmann; Geraldine Taylor
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  Infection of gnotobiotic calves with a bovine and human isolate of respiratory syncytial virus. Modification of the response by dexamethasone.

Authors:  L H Thomas; E J Stott; A P Collins; S Crouch; J Jebbett
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

7.  Development of nested PCR assays for detection of bovine respiratory syncytial virus in clinical samples.

Authors:  S Vilcek; M Elvander; A Ballagi-Pordány; S Belák
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

8.  A search for new microorganisms in calf pneumonia by the inoculation of gnotobiotic calves.

Authors:  L H Thomas; R N Gourlay; E J Stott; C J Howard; J C Bridger
Journal:  Res Vet Sci       Date:  1982-09       Impact factor: 2.534

9.  Studies on the relationship between coronaviruses from the intestinal and respiratory tracts of calves.

Authors:  D J Reynolds; T G Debney; G A Hall; L H Thomas; K R Parsons
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

Review 10.  Review on bovine respiratory syncytial virus and bovine parainfluenza - usual suspects in bovine respiratory disease - a narrative review.

Authors:  Birgit Makoschey; Anna Catharina Berge
Journal:  BMC Vet Res       Date:  2021-07-31       Impact factor: 2.741

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.